(19)

(11)

EP 4 460 258 A1

(12)

(43) Date of publication: 13.11.2024 Bulletin 2024/46 (21) Application number: 23703521.7 (22) Date of filing: 19.01.2023

(51) International Patent Classification (IPC):  A61B 90/00(2016.01) A61B 34/20(2016.01) B33Y 80/00(2015.01) (52) Cooperative Patent Classification (CPC): A61B 2034/2051; A61B 2034/2072; A61B 17/24; A61B 2017/00907; A61B 2034/2068; A61B 2090/3983; A61B 90/39; B33Y 80/00; A61B 2090/3762; A61B 2090/374 (86) International application number: PCT/IB2023/050473 (87) International publication number: WO 2023/144668 (03.08.2023 Gazette 2023/31)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 27.01.2022 US 202263303698 P 05.12.2022 US 202218074678 (71) Applicants: Acclarent, Inc. Irvine, CA 92618 (US) Biosense Webster (Israel) Ltd. 2066717 Yokneam (IL)

(72) Inventors: FANG, Itzhak Irvine, California 92614 (US) EBRAHIMI, Babak Irvine, California 92618 (US) SHAMELI, Ehsan Irvine, California 92618 (US) HOD, Uriel 2066717 Yokneam (IL) BUSTAN, Itamar 2066717 Yokneam (IL) PALUSHI, Jetmir Irvine, California 92620 (US) (74) Representative: Carpmaels & Ransford LLP  One Southampton Row London WC1B 5HA London WC1B 5HA (GB)